发明申请
![PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT](/docs/US/2014-06-05/US20140154240A1/abs.jpg.600x600.jpg)
- 专利标题： PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT
- 专利标题（中）： 吡咯并[1,5-A]用于抗病毒治疗的吡咯烷酮
-
申请号： US13905410申请日： 2013-05-30
-
公开(公告)号： US20140154240A1公开(公告)日： 2014-06-05
- 发明人: Kerim Babaoglu , Constantine G. Boojamra , Eugene J. Eisenberg , Hon Chung Hui , Richard L. Mackman , Jay P. Parrish , Michael Sangi , Oliver L. Saunders , Dustin Siegel , David Sperandio , Hai Yang
- 申请人： Gilead Sciences, Inc.
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/5377 ; A61K31/519 ; A61K45/06 ; A61K31/551 ; A61K31/55 ; C07D513/04 ; C07D495/04 ; A61K31/675 ; C07F9/6561
![PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT](/abs-image/US/2014/06/05/US20140154240A1/abs.jpg.150x150.jpg)
摘要：
The invention provides compounds of Formula I or Formula II: or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
公开/授权文献
- US09238039B2 Pyrazolo[1,5-A]pyrimidines for antiviral treatment 公开/授权日：2016-01-19